• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Model Number 10310
Device Problem Insufficient Information (3190)
Patient Problem Sepsis (2067)
Event Date 11/16/2022
Event Type  Injury  
Event Description
In journal article: "syngeneic hematopoietic stem cell transplantation after mobilization failure in an adolescent with intracranial germ cell tumor", by sánchez-sierra, n.Et al it was reported that the patient received hdct based on siop-cns-gct-ii guidelines and a non-manipulated syngeneic graft.Given the cellularity of the product (2.4 × 106 cd34+/kg), he received subcutaneous g-csf from day+5 to 2 days after reaching the white blood cell graft (day+9) as well as corticosteroid prophylaxis of the engraftment syndrome.As main complications, he developed escherichia coli sepsis, grade 3 hyperemesis, and mucositis.Antiviral and antibiotic prophylaxis was discontinued 4 months after shsct.The patient continued treatment as planned with focal proton beam radiation therapy.He ended treatment 8 months after diagnosis and is currently in complete remission.Patient id and weight are not available at this time as they were not included in the article for this event.The disposable set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Lot number and expiry information were not included in the article and are not available.Investigation is in process, a follow-up report will be provided.Citation: sánchez-sierra, n., perez-somarriba, m., santa-maria, v., cruz, o., garcía-rey, e., martorell, l., rovira, m., margarit, a., & marsal, j.(2023).Syngeneic hematopoietic stem cell transplantation after mobilization failure in an adolescent with intracranial germ cell tumor.Pediatric blood & cancer, 70(5).Https://doi.Org/10.1002/pbc.30177.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilton
10810 w. collins ave
lakewood, CO 80215
MDR Report Key16887541
MDR Text Key314753402
Report Number1722028-2023-00172
Device Sequence Number1
Product Code LKN
UDI-Device Identifier05020583103108
UDI-Public05020583103108
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number10310
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/13/2023
Initial Date FDA Received05/08/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age13 YR
Patient SexMale
-
-